
There was unfortunate news for Sanofi and Zealand Pharma as the FDA announced that it required additional information, constituting a …
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand

